Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
983.6 INR | -0.89% | -3.63% | +42.72% |
May. 13 | Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets | MT |
May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
Sales 2024 * | 193B 2.31B | Sales 2025 * | 210B 2.52B | Capitalization | 999B 11.97B |
---|---|---|---|---|---|
Net income 2024 * | 35.8B 429M | Net income 2025 * | 37.34B 447M | EV / Sales 2024 * | 5.11 x |
Net cash position 2024 * | 13.47B 161M | Net cash position 2025 * | 33.33B 399M | EV / Sales 2025 * | 4.59 x |
P/E ratio 2024 * |
27.7
x | P/E ratio 2025 * |
26.6
x | Employees | 23,026 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.59% | Free-Float | 24.87% |
Latest transcript on Zydus Lifesciences Limited
1 day | -0.87% | ||
1 week | +0.31% | ||
Current month | +3.18% | ||
1 month | +5.21% | ||
3 months | +13.37% | ||
6 months | +58.39% | ||
Current year | +42.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 97-07-31 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 95-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 18-12-05 | |
Chairman | 71 | 95-05-14 | |
Director/Board Member | 69 | 97-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.22% | 6 M€ | +6.07% | - | |
0.01% | 112 M€ | +4.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 983.6 | -0.89% | 799 850 |
24-05-13 | 992.5 | +1.05% | 1,082,684 |
24-05-10 | 982.2 | +1.44% | 1,020,700 |
24-05-09 | 968.2 | -3.72% | 1,322,296 |
24-05-08 | 1,006 | +2.52% | 1,456,376 |
Delayed Quote NSE India S.E., May 14, 2024 at 05:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.75% | 11.96B | |
+22.68% | 43.81B | |
+25.56% | 23.01B | |
+18.63% | 15.27B | |
+8.85% | 13.68B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B | |
+10.29% | 4.92B |
- Stock Market
- Equities
- ZYDUSLIFE Stock